Crosstalk between interleukin-6 and corticotropin-releasing factor modulate submucosal plexus activity and colonic secretion

Brain, Behavior, and Immunity

Volumn 30, Issue , 2013, Pages 115-124

  O'Malley, Dervla ^a,b   Cryan, John F ^a,b   Dinan, Timothy G ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Corticotropin releasing factor; Interleukin 6; Irritable bowel syndrome; Secretion; Submucosal plexus

Indexed keywords

CALCIUM; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; COLONIC SECRETION; DESCENDING COLON; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINAL SECRETIONS; IRRITABLE COLON; MALE; MATERNAL DEPRIVATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; COLON; CORTICOTROPIN-RELEASING HORMONE; FEMALE; INTERLEUKIN-6; IRRITABLE BOWEL SYNDROME; MALE; MATERNAL DEPRIVATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; SUBMUCOUS PLEXUS;

EID: 84876881409     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.01.078     Document Type: Article

References (46)

1. Barreau F., Cartier C., Leveque M., Ferrier L., Moriez R., Laroute V., Rosztoczy A., Fioramonti J., Bueno L. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J. Physiol. 2007, 580:347-356.
2. Bisschops R., Vanden Berghe P., Sarnelli G., Janssens J., Tack J. CRF-induced calcium signaling in guinea pig small intestine myenteric neurons involves CRF-1 receptors and activation of voltage-sensitive calcium channels. Am. J. Physiol. 2006, 290:G1252-G1260.
3. Bohmelt A.H., Nater U.M., Franke S., Hellhammer D.H., Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosom. Med. 2005, 67:288-294.
4. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D., Greenberg M.E. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997, 278:477-483. New York, N.Y.
5. Buhner S., Li Q., Vignali S., Barbara G., De Giorgio R., Stanghellini V., Cremon C., Zeller F., Langer R., Daniel H., Michel K., Schemann M. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009, 137:1425-1434.
6. Chadwick V.S., Chen W., Shu D., Paulus B., Bethwaite P., Tie A., Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122:1778-1783.
7. Chatzaki E., Crowe P.D., Wang L., Million M., Tache Y., Grigoriadis D.E. CRF receptor type 1 and 2 expression and anatomical distribution in the rat colon. J. Neurochem. 2004, 90:309-316.
8. Clarke G., Quigley E.M., Cryan J.F., Dinan T.G. Irritable bowel syndrome: towards biomarker identification. Trends Mol. Med. 2009, 15(10):478-489.
9. Dinan T.G., Clarke G., Quigley E.M., Scott L.V., Shanahan F., Cryan J., Cooney J., Keeling P.W. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am. J. Gastroenterol. 2008, 103:2570-2576.
10. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., O'Mahony S., Shanahan F., Keeling P.W. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
11. Folks D.G. The interface of psychiatry and irritable bowel syndrome. Curr. Psychiatry Rep. 2004, 6:210-215.
12. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
13. Gibney S.M., Gosselin R.D., Dinan T.G., Cryan J.F. Colorectal distension-induced prefrontal cortex activation in the Wistar-Kyoto rat: implications for irritable bowel syndrome. Neuroscience 2010, 165:675-683.
14. Heitkemper M., Jarrett M., Cain K., Shaver J., Bond E., Woods N.F., Walker E. Increased urine catecholamines and cortisol in women with irritable bowel syndrome. Am. J. Gastroenterol. 1996, 91:906-913.
15. Kindt S., Vanden Berghe P., Boesmans W., Roosen L., Tack J. Prolonged IL-1beta exposure alters neurotransmitter and electrically induced Ca responses in the myenteric plexus. Neurogastroenterol. Motil. 2009, 22(3):321-385.
16. Lakshmanan J., Magee T.R., Richard J.D., Liu G.L., Salido E., Sugano S.K., Ferrini M., Ross M.G. Localization and gestation-dependent pattern of corticotrophin-releasing factor receptor subtypes in ovine fetal distal colon. Neurogastroenterol. Motil. 2008, 20:1328-1339.
17. Larauche M., Gourcerol G., Wang L., Pambukchian K., Brunnhuber S., Adelson D.W., Rivier J., Million M., Tache Y. Cortagine, a CRF1 agonist, induces stress like alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. Am. J. Physiol. 2009, 297:G215-G227.
18. Larauche M., Kiank C., Tache Y. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications. J. Physiol. Pharmacol. 2009, 60(Suppl. 7):33-46.
19. Liebregts T., Adam B., Bredack C., Roth A., Heinzel S., Lester S., Downie-Doyle S., Smith E., Drew P., Talley N.J., Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920.
20. Liu S., Gao X., Gao N., Wang X., Fang X., Hu H.Z., Wang G.D., Xia Y., Wood J.D. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system. J. Comp. Neurol. 2005, 481:284-298.
21. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995, 136:4139-4142.
22. Macsharry J., O'Mahony L., Fanning A., Bairead E., Sherlock G., Tiesman J., Fulmer A., Kiely B., Dinan T.G., Shanahan F., Quigley E.M. Mucosal cytokine imbalance in irritable bowel syndrome. Scand. J. Gastroenterol. 2008, 43:1467-1476.
23. Maillot C., Million M., Wei J.Y., Gauthier A., Tache Y. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats. Gastroenterology 2000, 119:1569-1579.
24. Natale L., Piepoli A.L., De Salvia M.A., De Salvatore G., Mitolo C.I., Marzullo A., Portincasa P., Moschetta A., Palasciano G., Mitolo-Chieppa D. Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study. Eur. J. Clin. Invest. 2003, 33:704-712.
25. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F., Quigley E.M. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
26. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., Cryan J.F., Dinan T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 2009, 65:263-267.
27. O'Malley D., Dinan T.G., Cryan J.F. Alterations in colonic corticotropin-releasing factor receptors in the maternally separated rat model of irritable bowel syndrome: differential effects of acute psychological and physical stressors. Peptides 2010, 31:662-670.
28. O'Malley D., Dinan T.G., Cryan J.F. Altered expression and secretion of colonic interleukin-6 in a stress-sensitive animal model of brain-gut axis dysfunction. J. Neuroimmunol. 2011, 235:48-55.
29. O'Malley D., Julio-Pieper M., Gibney S.M., Dinan T.G., Cryan J.F. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour. Stress 2010, 13:114-122.
30. O'Malley D., Julio-Pieper M., Gibney S.M., Gosselin R.D., Dinan T.G., Cryan J.F. Differential stress-induced alterations of colonic corticotropin-releasing factor receptors in the Wistar Kyoto rat. Neurogastroenterol. Motil. 2010, 22:301-311.
31. O'Malley D., Liston M., Hyland N.P., Dinan T.G., Cryan J.F. Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism. Am. J. Physiol. 2011, 300:G241-G252.
32. O'Malley D., Quigley E.M., Dinan T.G., Cryan J.F. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome?. Brain Behavior Immun. 2011, 25:1333-1341.
33. Piche T., Barbara G., Aubert P., Bruley des Varannes S., Dainese R., Nano J.L., Cremon C., Stanghellini V., De Giorgio R., Galmiche J.P., Neunlist M. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009, 58:196-201.
34. Porcher C., Juhem A., Peinnequin A., Sinniger V., Bonaz B. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine. Am. J. Physiol. 2005, 288:G1091-G1103.
35. Quigley E.M. Changing face of irritable bowel syndrome. World J. Gastroenterol. 2006, 12:1-5.
36. Saunders P.R., Maillot C., Million M., Tache Y. Peripheral corticotropin-releasing factor induces diarrhea in rats: role of CRF1 receptor in fecal watery excretion. Eur. J. Pharmacol. 2002, 435:231-235.
37. Scully P., McKernan D.P., Keohane J., Groeger D., Shanahan F., Dinan T.G., Quigley E.M. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am. J. Gastroenterol. 2010, 105(10):2235-2243.
38. Semnani S., Roshandel G., Keshtkar A., Najafi L., Amiriani T., Farajollahi M., Moradi A., Joshaghani H. Serum leptin levels and irritable bowel syndrome: a new hypothesis. J. Clin. Gastroenterol. 2009, 43:826-830.
39. Sengupta T.K., Talbot E.S., Scherle P.A., Ivashkiv L.B. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc. Natl. Acad. Sci. USA 1998, 95:11107-11112.
40. Song C., Earley B., Leonard B.E. Behavioral, neurochemical and immunological responses to CRF administration. Is CRF a mediator of stress?. Ann. N.Y. Acad. Sci. 1995, 771:55-72.
41. Tache Y., Kiank C., Stengel A. A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr. Gastroenterol. Rep. 2009, 11:270-277.
42. Tache Y., Perdue M.H. Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function. Neurogastroenterol. Motil. 2004, 16(Suppl. 1):137-142.
43. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156.
44. Wigger A., Neumann I.D. Periodic maternal deprivation induces gender-dependent alterations in behavioral and neuroendocrine responses to emotional stress in adult rats. Physiol. Behav. 1999, 66:293-302.
45. Xia Y., Hu H.Z., Liu S., Ren J., Zafirov D.H., Wood J.D. IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system. J. Clin. Invest. 1999, 103:1309-1316.
46. Yuan P.Q., Million M., Wu S.V., Rivier J., Tache Y. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol. Motil. 2007, 19:923-936.